[HTML][HTML] Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies
Background Patients with coronavirus disease 2019 (COVID-19) who have underlying
malignancy have a higher mortality rate compared with those without cancer, although the …
malignancy have a higher mortality rate compared with those without cancer, although the …
COVID-19 and cancer: current challenges and perspectives
Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta …
Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: a …
Importance SARS-CoV-2 infection has been associated with more severe disease and
death in patients with cancer. However, the implications of certain tumor types, treatments …
death in patients with cancer. However, the implications of certain tumor types, treatments …
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French …
Background Cancer patients are thought to have an increased risk of develo** severe
Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work …
Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work …
[HTML][HTML] Severity of COVID-19 in patients with lung cancer: evidence and challenges
A Passaro, C Bestvina, MV Velez… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts
with the healthcare system, immunocompromised state from cancer or its therapies …
with the healthcare system, immunocompromised state from cancer or its therapies …
The immuno-oncological challenge of COVID-19
Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …
considerable challenges for the management of oncology patients. COVID-19 presents as a …
Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 Registry
Methods| The Cleveland Clinic initiated a COVID-19 registry starting on March 8, 2020, that
includes all patients tested for COVID-19 within the Cleveland Clinic Health system in Ohio …
includes all patients tested for COVID-19 within the Cleveland Clinic Health system in Ohio …
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research
NL Benowitz, ML Goniewicz… - The Lancet …, 2022 - thelancet.com
Heterogeneity in the clinical presentation of SARS-CoV-2 infection and COVID-19
progression underscores the urgent need to identify individual-level susceptibility factors …
progression underscores the urgent need to identify individual-level susceptibility factors …